Register for free to
view the full innovation profile.
New peptoids have been created that prevent the aggregation of the beta amyloids, and may break up existing amyloids.
About
New peptoids have been created that prevent the aggregation of the beta amyloids, and may break up existing amyloids. These peptoids are currently being tested and research is on-going. The new peptoids may be developed into drugs which could be administered to Alzheimer‚ patients to prevent further damage to their brains, and possibly even to reverse the effects of the disease.
Key Benefits
Currently there are no known therapies available that prevent the progression of Alzheimer's Disease.
Applications
Therapeutics for protein aggregation diseases, including Alzheimer's Disease